Altered Amyloid-β42 and BACE-1 Proteins in Plasma Astrocyte-Derived Exosomes in Hypertensive Patients With Cerebral Microbleeds
American Journal of Hypertension · 2026
DOI: 10.1093/ajh/hpaf158 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Hypertension, 2026. Verfasst von Xiaoxiao Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Amyloid Precursor Protein Secretases, Exosomes, Aspartic Acid Endopeptidases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Medical and Health Technology Development Program in Shandong Province.
Abstract (Originalsprache)
BACKGROUND Cerebral microbleeds (CMBs) have been found to promote Alzheimer’s disease (AD) progression. Hypertension (HTN) is one of the major etiological factors for CMBs and an important risk factor for AD. However, the association between HTN-related CMBs and AD pathology remains undetermined. This study aims to identify the relationship between HTN-related CMBs and amyloid-β 42 (Aβ42) and β-site amyloid precursor protein cleaving enzyme 1 (BACE-1) levels in plasma astrocyte-derived exosomes (ADEs). METHODS In total, 88 HTN participants including 30 with deep/infratentorial (D/I) CMBs, 30 with mixed CMBs, and 28 without CMBs were analyzed. Susceptibility-weighted imaging was performed to assess the location, presence, and number of CMBs. ELISA kits for BACE-1 and Aβ42 were employed to evaluate the levels of astrocyte-derived exosomal proteins. RESULTS The results indicated that plasma ADE levels of Aβ42 were reduced in the HTN + D/I CMBs and HTN + Mixed CMBs groups relative to the HTN-CMBs group. Furthermore, the plasma ADE levels of Aβ42 were significantly associated with CMBs in patients with HTN. However, no significant differences were found in the plasma ADE levels of BACE-1 among the HTN + D/I CMBs, HTN + Mixed CMBs, and HTN-CMBs groups. CONCLUSIONS The study revealed that reduced plasma ADE levels of Aβ42 were significantly associated with CMBs in HTN patients. This finding suggests a potential link between HTN-related CMBs and AD-related amyloid-β pathology, offering novel insights into the mechanisms by which HTN-related CMBs promote AD progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Weihai Municipal Hospital, Cheeloo College of Medicine, Shandong University, Weihai, China.
ORCID-Profile: Xiaoxiao Liu, Jinbiao Zhang
Förderung
- Medical and Health Technology Development Program in Shandong Province
Zitieren
APA
Liu, X., Liu, Y., Yao, R., Li, M., Shen, T., Leng, B., Sun, H., Li, Z., & Zhang, J. (2026). Altered Amyloid-β42 and BACE-1 Proteins in Plasma Astrocyte-Derived Exosomes in Hypertensive Patients With Cerebral Microbleeds. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpaf158
Vancouver
Liu X, Liu Y, Yao R, Li M, Shen T, Leng B, et al. Altered Amyloid-β42 and BACE-1 Proteins in Plasma Astrocyte-Derived Exosomes in Hypertensive Patients With Cerebral Microbleeds. American Journal of Hypertension. 2026. doi:10.1093/ajh/hpaf158
BibTeX
@article{Liu2026,
author = {Liu, Xiaoxiao and Liu, Yuanyuan and Yao, Ran and Li, Mengfan and Shen, Tengqun and Leng, Bing and Sun, Hairong and Li, Zhenguang and Zhang, Jinbiao},
title = {Altered Amyloid-β42 and BACE-1 Proteins in Plasma Astrocyte-Derived Exosomes in Hypertensive Patients With Cerebral Microbleeds},
journal = {American Journal of Hypertension},
year = {2026},
doi = {10.1093/ajh/hpaf158}
}
EUVIMED